Table 2.

Adverse events in Study 1

Adverse event	ILSb-3 injections			ILSb-5 injections			ILPenta-120-3 injections
	Mild	Moderate	Severe	Mild	Moderate	Severe	Mild	Moderate	Severe
Myalgias	2	0	0	1	0	0	0	0	0
Nausea	0	0	0	0	0	0	0	0	0
Sterile abscess	0	0	0	0	0	0	0	0	0
Low blood pressure	0	0	0	0	0	0	0	0	0
Low glucose	nd	nd	nd	nd	nd	nd	0	0	0
Local irritation	8	0	0	7	0	0	3	1	0
Local pain	6	2	0	4	2	0	1	2	0

ILPenta = intralesional pentamidine; ILSb = intralesional therapy with antimony; nd = not done. For definitions of mild/moderate/severe, see Materials and Methods.